Rudolf Prager

10.5k total citations · 1 hit paper
140 papers, 5.4k citations indexed

About

Rudolf Prager is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Rudolf Prager has authored 140 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Endocrinology, Diabetes and Metabolism, 45 papers in Surgery and 30 papers in Molecular Biology. Recurrent topics in Rudolf Prager's work include Diabetes Treatment and Management (48 papers), Diabetes Management and Research (35 papers) and Pancreatic function and diabetes (31 papers). Rudolf Prager is often cited by papers focused on Diabetes Treatment and Management (48 papers), Diabetes Management and Research (35 papers) and Pancreatic function and diabetes (31 papers). Rudolf Prager collaborates with scholars based in Austria, Germany and Italy. Rudolf Prager's co-authors include Jerrold M. Olefsky, Giovanni Pacini, Bernhard Ludvik, Alexandra Kautzky‐Willer, Richard N. Bergman, Aage Vølund, Penny Wallace, G. Schernthaner, Guntram Schernthaner and Karl Thomaseth and has published in prestigious journals such as Journal of Clinical Investigation, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Rudolf Prager

137 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.

1987 634 citations Rudolf Prager et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rudolf Prager Austria	38	2.5k	1.4k	1.2k	1.2k	986	140	5.4k
P. Cavallo‐Perin Italy	36	2.2k 0.9×	1.1k 0.8×	1.0k 0.8×	952 0.8×	1.3k 1.3×	128	5.7k
Timon W. van Haeften Netherlands	31	2.4k 1.0×	1.6k 1.2×	1.3k 1.1×	1.7k 1.5×	889 0.9×	79	6.2k
Shigehiro Katayama Japan	45	2.5k 1.0×	1.2k 0.9×	1.1k 0.9×	2.7k 2.3×	1.8k 1.9×	224	8.2k
Kishio Nanjo Japan	29	1.6k 0.7×	1.3k 0.9×	910 0.7×	1.2k 1.0×	687 0.7×	91	4.4k
Nicola Abate United States	36	1.9k 0.8×	1.1k 0.8×	2.2k 1.8×	1.1k 0.9×	1.3k 1.3×	84	6.2k
Antonio Tiengo Italy	50	3.3k 1.3×	1.8k 1.3×	1.9k 1.5×	2.6k 2.3×	1.3k 1.3×	220	8.1k
Anna Solini Italy	48	2.6k 1.1×	1.3k 1.0×	1.3k 1.0×	1.9k 1.6×	1.5k 1.5×	233	7.4k
Kristian F. Hanssen Norway	40	2.7k 1.1×	1.2k 0.9×	567 0.5×	686 0.6×	785 0.8×	143	5.5k
Francesco Andreozzi Italy	46	2.4k 1.0×	1.1k 0.8×	1.3k 1.1×	2.0k 1.7×	1.3k 1.3×	213	6.2k
Jan Erik Henriksen Denmark	42	1.9k 0.8×	705 0.5×	843 0.7×	1.3k 1.1×	670 0.7×	128	4.6k

Countries citing papers authored by Rudolf Prager

Since Specialization

Citations

This map shows the geographic impact of Rudolf Prager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Prager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Prager more than expected).

Fields of papers citing papers by Rudolf Prager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf Prager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Prager. The network helps show where Rudolf Prager may publish in the future.

Co-authorship network of co-authors of Rudolf Prager

This figure shows the co-authorship network connecting the top 25 collaborators of Rudolf Prager. A scholar is included among the top collaborators of Rudolf Prager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudolf Prager. Rudolf Prager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Resl, Michael, Greisa Vila, A Luger, et al.. (2021). Changes in the prognostic values of modern cardiovascular biomarkers in relation to duration of diabetes mellitus. Journal of Diabetes and its Complications. 35(9). 107990–107990. 7 indexed citations

Resl, Michael, Martin Clodi, Greisa Vila, et al.. (2016). Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes. Heart. 102(24). 1963–1968. 32 indexed citations

Resl, Michael, Martin Clodi, Stephanie Neuhold, et al.. (2011). Serum uric acid is related to cardiovascular events and correlates with N‐terminal pro‐B‐type natriuretic peptide and albuminuria in patients with diabetes mellitus. Diabetic Medicine. 29(6). 721–725. 21 indexed citations

Neuhold, Stephanie, Michael Resl, M Huelsmann, et al.. (2011). Repeat measurements of glycated haemoglobin A_1c and N‐terminal pro‐B‐type natriuretic peptide: divergent behaviour in diabetes mellitus. European Journal of Clinical Investigation. 41(12). 1292–1298. 17 indexed citations

Stadler, Marietta, Christian Anderwald, Martin Auinger, et al.. (2009). Persistent arterial stiffness and endothelial dysfunction following successful pancreas–kidney transplantation in Type 1 diabetes. Diabetic Medicine. 26(10). 1010–1018. 14 indexed citations

Huelsmann, M, Stephanie Neuhold, Guido Strunk, et al.. (2008). NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus. European Heart Journal. 29(18). 2259–2264. 64 indexed citations

Liebl, Andreas, Rudolf Prager, Katharina Binz, et al.. (2008). Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial. Diabetes Obesity and Metabolism. 11(1). 45–52. 125 indexed citations

Bohdjalian, Arthur, Bernhard Ludvik, Bruno Guerci, et al.. (2008). Improvement in glycemic control by gastric electrical stimulation (TANTALUSTM) in overweight subjects with type 2 diabetes. Surgical Endoscopy. 23(9). 1955–1960. 20 indexed citations

Krebs, Michael, Miriam Promintzer, Martin Bischof, et al.. (2007). Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. American Journal of Physiology-Endocrinology and Metabolism. 293(5). E1393–E1398. 57 indexed citations

10.

Abrahamian, Heidemarie, Georg Endler, Markus Exner, et al.. (2007). Association of Low-Grade Inflammation with Nephropathy in Type 2 Diabetic Patients: Role of Elevated CRP-Levels and 2 Different Gene-Polymorphisms of Proinflammatory Cytokines. Experimental and Clinical Endocrinology & Diabetes. 115(1). 38–41. 35 indexed citations

11.

Kautzky‐Willer, Alexandra, Andrea Tura, Christine Winzer, et al.. (2006). Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione. Diabetes Obesity and Metabolism. 8(5). 561–567. 16 indexed citations

12.

Hanusch‐Enserer, Ursula, Katharina Hermann, Edmund Cauza, et al.. (2003). Effect of Gastric Banding on Aminoterminal Pro‐brain Natriuretic Peptide in the Morbidly Obese. Obesity Research. 11(6). 695–698. 22 indexed citations

13.

Hanusch‐Enserer, Ursula, Attila Dunky, Harald Rosén, et al.. (2003). Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. International Journal of Obesity. 27(3). 355–361. 50 indexed citations

14.

Clodi, Martin, Karl Thomaseth, Giovanni Pacini, et al.. (1998). Distribution and kinetics of amylin in humans. American Journal of Physiology-Endocrinology and Metabolism. 274(5). E903–E908. 28 indexed citations

15.

Griesmacher, Andrea, Sylvia Andert, Wolfgang Schreiner, et al.. (1995). Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. The American Journal of Medicine. 98(5). 469–475. 248 indexed citations

16.

Schnack, Ch., et al.. (1994). Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria. Acta Diabetologica. 31(1). 14–18. 24 indexed citations

17.

Niederle, Bruno, et al.. (1992). Primary hyperparathyroidism in Austria: Results of an 8‐year prospective study. World Journal of Surgery. 16(4). 777–782. 11 indexed citations

18.

Klauser, Renate, Rudolf Prager, Bruno Watschinger, & Guntram Schernthaner. (1989). Metabolic effects of biosynthetic human proinsulin in type 2 diabetes mellitus. European Journal of Clinical Investigation. 19(5). 466–471. 3 indexed citations

19.

Prager, Rudolf. (1989). [Treatment of hyperlipidemia with HMG-CoA reductase inhibitors].. PubMed. 105. 17–20. 1 indexed citations

20.

Prager, Rudolf, et al.. (1984). Primary hyperparathyroidism is associated with decreased insulin receptor binding and glucose intolerance. Calcified Tissue International. 36(1). 253–258. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact